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Abstract
Background: The role of Mycobacteria in the etiology of Crohn's disease (CD) has been a
contentious subject for many years. Recently, our laboratory showed that spontaneous colitis in
IL-10-/- mice is driven in part by antigens (Ags) conserved in Mycobacteria. The present study
dissects some of the common cellular and molecular mechanism that drive Mycobacteria-mediated
and spontaneous colitis in IL-10-/- mice.
Results: We show that serum from inflammatory bowel disease (IBD) patients contain significantly
higher levels of Mycobacterium avium paratuberculosis-specific IgG1 and IgG2 antibodies (Abs), serum
amyloid A (SAA) as well as CXCR3 ligands than serum from healthy donors. To study the cellular
mechanisms of Mycobacteria-associated colitis, pathogen-free IL-10-/- mice were given heat-killed or
live M. avium paratuberculosis. The numbers of mucosal T cells, neutrophils, NK/NKT cells that
expressed TNFα, IFN-γ, and/or CXCL10 were significantly higher in mice that received live
Mycobacteria than other groups. The numbers of mucosal CXCR3+, CXCL9+, CXCL11+ and/or
IFN-γ+ dendritic cells (DCs) were also significantly higher in M. avium paratuberculosis-challenged
mice, than compared to control mice.
Conclusion: The present study shows that CD and UC patients mount significant Mycobacteria-
specific IgG1 > IgG2 and CXCR3 ligand responses. Several cellular mechanisms that drive
spontaneous colitis also mediate Mycobacteria-enhanced colitis in IL-10-/- mice. Similar to IL-10-/-
mice under conventional housing, we show that Mycobacteria-challenge IL-10-/- mice housed under
otherwise pathogen-free conditions develop colitis that is driven by CXCR3- and CXCR3 ligand-
expressing leukocytes, which underscores another important hallmark and molecular mechanism
of colitis. Together, the data show that Mycobacteria-dependent host responses, namely CXCL10+
T cells and NK cells, assist in the recruitment and activation of CXCR3+ and CXCL11+ leukocytes
to enhance colitis of susceptible hosts.
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Background
Although increasing evidence suggests that intestinal flora
is involved in the pathogenesis of IBD, to date no specific
bacterial pathogen has been identified as the cause of this
disease. The role of Mycobacteria in the etiology of IBD has
been a contentious subject for many years. The possible
association between M. avium paratuberculosis and CD in
humans was first suggested nearly 100 years ago because
Johne's disease (JD) and CD have similar histological and
pathological features with affected tissues containing
granulomas [1]. Interest in a causal association between
JD and CD was stimulated in the 1980s after M. avium
paratuberculosis  was isolated from material taken from
patients with CD [1,2]; subsequent studies confirmed
these results [3,4]. This premise is further supported by
successful CD treatment with anti-mycobacterials con-
taining macrolide antibiotics [5] and from the sero-reac-
tivity of the CD patient serum samples against M. avium
paratuberculosis [6]. Recently, we reported that humoral
and cellular responses during spontaneous colitis in IL-10-
/- mice are driven in part by conserved Ags in Mycobacte-
rium species [7]. Together, these studies form a wide body
of evidence that supports the potential role for Mycobacte-
ria in CD. However, an incomplete understanding of the
cellular mechanisms responsible for the pathology of col-
itis makes this conclusion uncertain.
There is a consensus that the mucosa of CD patients is
dominated by Th1 cell producing inflammatory cytokines
[8,9]. CXCR3 interactions with CXCL9, CXCL10 and
CXCL11 are important for the selective homing of Th1
effectors cells [10], which mediate mucosal immunity,
inflammation, and colitis [11,12]. IL-10-/- mice develop
spontaneous colitis that has similarities to human CD at
~3 months of age under conventional housing conditions
which can be abrogated by anti-CXCL10 Ab treatment.
The present study explores the CXCR3 axis and cellular
mechanisms that drive Mycobacteria-associated colitis in
IL-10-/- mice. We also report that serum from both CD and
UC patients contain significantly higher Mycobacteria-spe-
cific IgG1 and IgG2 Ab responses as well as CXCL9,
CXCL10, CXCL11 and SAA levels than compared to nor-
mal healthy donors. These innate and adaptive immune
responses coincide with Mycobacteria-specific humoral
and cellular responses and modulation of mesenteric
lymph node (MLN), Peyer's patch (PP) and lamina pro-
pria (LP) Th1-associated cytokines and CXCR3 ligands
expressed by DCs, T cells, neutrophils and NK/NKT cell
subsets following Mycobacteria challenge of otherwise spe-
cific pathogen-free mice.
Methods
Immunogens
M. avium paratuberculosis strain Ben (CIP 103966), a clin-
ical isolate from a CD patient, was obtained from the
American Type Culture Collection (ATCC# 43544). Bacte-
ria were cultured in Middlebrook 7H9 broth supple-
mented with 10% ADC (BD/Difco) and 2 μg/ml
mycobactin J (Allied Monitor) to an OD580 of 0.5 and fro-
zen. The viable titer of these stocks was determined by
thawing replicates, serial dilution in culture medium and
plating on Middlebrook 7H10 agar supplemented with 2
μg/ml of mycobactin J. For detection of Mycobacteria-spe-
cific responses, M. avium paratuberculosis bacilli were fixed
with 2% paraformaldehyde.
Sera collection
Sera from 62 CD and 88 UC female patients and 32 nor-
mal healthy female donors were collected by Clinomics
Biosciences, Inc. The ages of the patients were 20 to 41
years. Diagnoses were based on clinical, radiological,
endoscopic, and histological criteria. These patients did
not receive any steroid treatment before blood was drawn.
All subjects gave written informed consent and the study
was approved by the Clinomics Biosciences Research Eth-
ics Committee, (Pittsfield, MA, USA). Subsequently, the
University of Louisville Institutional Review Board (IRB)
approved the use of these diagnostic specimens in accord-
ance with the Department of Health and Human Service
Policy for the Protection of Human Research Subjects 45
CFR 46.101(b) 2 and use of archived de-identified mate-
rials.
Mycobacterium-specific Ab detection by ELISA
Mycobacteria
manufacturer's protocol (Invitrogen-Zymed). Briefly, 96-
well Falcon ELISA plates (Fisher Scientific) were coated
with 100 μl of 1 μg/ml of heat-killed and paraformalde-
hyde-fixed  M. avium paratuberculosis in coating buffer
(sodium carbonate-bicarbonate buffer) or serially diluted
human IgG1, IgG2, IgG3, and IgG4 isotype controls over-
night at 4°C and blocked with 200 μl of 10% FBS (Atlanta
Biologicals) in PBS (FBS-PBS) for 2 hours at room temper-
ature. Individual samples were added and serially diluted
in FBS-PBS. After 4 hours incubation at room tempera-
ture, the plates were washed (3 times), and the concentra-
tions of IgG subclass Abs were determined by the addition
100 μl of biotin-conjugated mouse anti-human γ1 (Clone
8c/6-39 at 12.5 ng/ml), γ2 (Clone HP-6014 at 125 ng/
ml), γ3 (Clone HP-6050 at 12.5 ng/ml), and γ4 (Clone
HP-6025 at 50 ng/ml) heavy-chain-specific monoclonal
Abs. After the incubation and washing steps, 100 μl of 0.5
μg/ml horse radish peroxidase (HRP)-conjugated anti-
biotin Ab (Vector Labs) in FBS-PBS was added to IgG sub-
class Ab detection wells, and the plates were incubated for
2 hours at room temperature. Following incubation, the
plates were washed 6 times and developed by adding 100
μl of ABTS solution and read at 415 nm. The Mycobacte-
rium-specific ELISA assays were capable of detecting 8 pg/
ml for human IgG subclass samples.BMC Immunology 2008, 9:25 http://www.biomedcentral.com/1471-2172/9/25
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Chemokine analysis by ELISA
Serum concentrations of human CXCL9, CXCL10 and
CXCL11 were determined by ELISA (R&D Systems),
according to the manufacturer's instructions. In brief, 96-
well ELISA plates were coated with capture Abs, and the
plates were incubated overnight at room temperature.
After blocking, 100 μl of sample or standards were added
to each well, and the plates were incubated for 2 hours at
room temperature. Then, 100 μl of detection Abs solution
was added to each well, and the plates were further incu-
bated for 2 hours at room temperature. After washing the
plates, 100 μl of streptavidin-HRP solution was added,
and the plates were incubated for 20 min in the dark.
Next, 100 μl of substrate solution was added to the plates,
which were incubated for an additional 20 min at room
temperature in the dark. Finally, 50 μl of the stop solution
was added, and the plates were read at an optical density
of 450 nm after 30 min using λ corrections of 540 and 570
nm. The ELISA assays were capable of detecting >10 pg/ml
of each chemokine.
SAA ELISA
SAA levels were determined by ELISA kit (Biosource Inter-
national, Camarillo, CA). In brief, 50 μl of SAA-specific
mAb solution was used to coat micro-titer strips to capture
SAA. Serum samples and standards were added to wells
and incubated for 2 hr at RT. After washing in the assay
buffer, the HRP-conjugated anti-SAA mAb solution was
added, and the plates were incubated for 1 hr at 37°C.
After washing, 100 μl tetra-methyl-benzidine (TMB) sub-
strate solution was added, and the reaction was stopped
after incubation for 15 minute at RT. After the addition of
stop solution, the plates were read at an optical density of
450 nm.
Animals and M. avium paratuberculosis challenge
Female 4 to 5 weeks old IL-10-/- mice, on B6 background,
were purchased from Jackson Laboratories (Bar Harbor,
ME) and used to establish a colony at the Morehouse
School of Medicine animal facility. The animals were
housed and maintained in isolator cages under specific-
pathogen-free housing conditions. The guidelines pro-
posed by the Committee for the Care of Laboratory Ani-
mal Resources Commission of Life Sciences-National
Research Council were followed to minimize animal pain
and distress. To determine the cellular responses
enhanced by Mycobacteria, groups of naïve IL-10-/- mice
received 200 μl of 104 CFU live or heat-killed (pasteur-
ized; 65°C for 2 hours) M. avium paratuberculosis in cream
milk or cream milk alone (control) by oral gavage. Mice
were sacrificed by CO2 inhalation 14 weeks post inocula-
tion. Each experimental group consisted of 5 to 10 mice.
Cell isolation
Spleens and MLN from individual mice were mechani-
cally dissociated, and red blood cells were lysed with ACK
lysis buffer (Sigma), 14 weeks after challenge. Single cell
suspensions of the spleens and MLN were passed through
a sterile wire screen (Sigma). Cell suspensions were
washed twice in RPMI 1640 and stored on ice in complete
medium containing 10% FBS until use. Cells from the LP
and PP were isolated as described previously [13]. After
removal, PP were kept on ice-cold RPMI containing 2%
FBS. Intestines were cut into 1 cm stripes and stirred in
PBS containing 1 mM EDTA at 37°C for 30 min. In brief,
the intestinal LP was isolated by digesting intestinal tissue
in collagenase type IV (Sigma) in RPMI 1640 (collagenase
solution), for 45 min with stirring at 37°C. After each 45-
minute interval, the released cells were centrifuged and
stored in complete medium, and remaining mucosal
pieces were replaced with fresh collagenase solution. LP
lymphocytes were further purified using a discontinuous
percoll (Pharmacia, Uppsala, Sweden) gradient, collecting
between the 40/75% percoll interface. Leukocytes were
maintained in a complete medium, which consisted of
RPMI 1640 supplemented with 10 ml/L of nonessential
amino acids (Mediatech, Washington, DC), 1 mM
sodium pyruvate (Sigma), 10 mM HEPES (Mediatech),
100 U/ml penicillin, 100 μg/ml streptomycin, 40 μg/ml
gentamycin (Elkins-Sinn, Inc., Cherry Hill, NJ), 50 μM
mercaptoethanol (Sigma), and 10% FBS (Atlanta Biologi-
cals).
Flow cytometry analysis
Leukocytes from the spleen, MLN, PP, and LP were iso-
lated as described above and stained to measure ex vivo
expression of chemokines and cytokines, 14 weeks after
challenge. Cells were first treated with Fc block (BD
PharMingen, San Diego CA) for 15 min at 4°C, washed
with staining buffer, and then stained with CY-, FITC- or
PE-conjugated anti-CD3 (145-2C11), -CD4 (H129.19), -
CD8 (LY-2 53-6.7), -CD11b (M1/70), -CD11c (HL3), and
-NK1.1 (PK136) (BD-PharMingen, San Diego CA) for 30
min with shaking. The cells were washed 2 times with
staining buffer and resuspended with BD Cytofix/
Cytoperm (BD-PharMingen) solution for 10 min each.
The cells were again washed 2 times in BD perm/wash
solution at 4°C for 10 min each. The fixed, permeabilized
cells were then resuspended in a pre-determined APC-
conjugated anti-CXCL10, CXCL9, CXCL11, TNF-α, IFN-γ,
or CXCR3 Ab for 30 min at 4°C in the dark. Lymphocytes
were then washed with FACS staining buffer (PBS with 1%
BSA) and fixed in 2% paraformaldehyde and analyzed by
flow cytometry (Becton Dickinson, San Diego, CA).
Histology
Intestinal tissues were preserved using Streck™ fixative
(Streck Laboratories, LaVista, NE) and embedded in paraf-
fin. Fixed tissues were sectioned at 6 μm and stained with
hematoxylin and eosin for microscopic examination.
Intestinal lesions were multi-focal and of variable severity.
The grades given to intestinal sections that took intoBMC Immunology 2008, 9:25 http://www.biomedcentral.com/1471-2172/9/25
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account the number of lesions as well as their severity. A
score (0 to 4) was given, based on the criteria described
previously [11]. The summation of these scores provided
a total colonic disease score per mouse. The disease score
could range from 0 to a maximum of 12 (with Grade 4
lesions in ascending, transverse, and descending colon
segments).
Statistics
The data expressed as the mean ± SEM and compared
using a two-tailed paired student's t-test or an unpaired
Mann Whitney U-test. The results were analyzed using the
Statview II statistical program (Abacus Concepts, Inc., Ber-
keley, CA) and Microsoft Excel (Microsoft, Seattle, WA)
for Macintosh computers. Single-factor and two-factor
variance ANOVA analyses were used to evaluate groups
and subgroups, respectively. Hence, results were consid-
ered statistically significant if p values were < 0.01.
Results
Changes in IgG subclass Ab profile in IBD patients
Previously, we have shown that serum Mycobacteria-spe-
cific IgG2a Ab responses were higher in IL-10-/- mice with
spontaneous colitis, than compared to control mice [7].
This previously described imbalance of the Th1 > Th2
cytokine levels as well as humoral response (IgG2a > >
IgG1) suggested that a Th1-biased host response is associ-
ated with the progression of colitis. To further test this
hypothesis in human subjects, we measured levels of
Mycobacteria-specific IgG subclass Abs in the sera of IBD
patients and healthy donors. While total IgG1, IgG2,
IgG3, and IgG4 subclass Abs were significantly higher in
the sera of IBD patients compared to healthy donors (data
not shown), the profile of the IgG humoral response in
IBD patients also revealed increases in Mycobacteria-spe-
cific IgG1 and IgG2 Abs (Figure 1). These responses in CD
patients were significantly higher than in UC patients or
normal healthy donors. CXCR3 ligands were also
increased in these samples than compared to healthy
donors. These results suggest that IBD patients have
higher CXCL9, CXCL10, and CXCL11 levels and Mycobac-
teria-specific IgG1 and IgG2 Ab responses. These findings
correlate well with our previous findings showing higher
levels of Mycobacteria-specific IgG2a and CXCR3 ligands
during spontaneous colitis in IL-10-/- mice under conven-
tional housing [7].
Characteristics of colitis progression
We also measured the SAA levels of IBD patients and
healthy donors; CD patients displayed significantly
higher SAA levels compared to other groups, which corre-
lated with the higher Mycobacteria-specific IgG2a levels
described above. Colitis progression in IL-10-/-  mice
closely corresponds with increased SAA levels (≥ 250 μg/
ml) and with reduction in body weight, compared with
the initial body weight [9,11,12]. The results of the
present study show that mice challenged with live Myco-
bacteria  in otherwise specific pathogen-free conditions
experienced a significant rise in SAA levels when com-
pared to similar mice challenged with heat-killed Myco-
bacteria or control mice (Figure 2). Despite the significant
increase in SAA and more pronounced reduction in body
mass, both live and heat-killed Mycobateria challenged IL-
10-/- mice developed histologically similar colitis than
compared to controls, as illustrated by significantly higher
colitis disease scores (Table 1). The intestinal tissues of
mice challenged with Mycobacteria  showed higher
increases in leukocyte infiltrates, which consisted of lym-
phocytes and occasionally polymorphonuclear cells as
well as a higher frequency of lymphoid follicles in live ver-
sus heat-killed Mycobacteria-challenged groups (Figure 3).
In short, colitis was more aggressive in mice that received
live  Mycobacteria, as noted by multi-focal lesions and
aggregates of leukocyte infiltrates in the large intestines,
than compared to control mice.
CXCR3, CXCL11, IFN-γ, and/or TNF-α expression by CD4+ 
and CD8+ T cells
To address the leukocyte subsets responsible for colitis
progression, we assessed the ex vivo expression of chemok-
ines and cytokines by MLN-, PP-, and LP-derived cell sub-
sets in IL-10-/- mice challenged with live or heat-killed M.
avium paratuberculosis bacilli. The numbers of CD4+ and
CD8+ T cells from MLN, PP, and LP lymphocytes that
Serum CXCR3 ligands and mycobacterial -specific Ab  responses in IBD patients Figure 1
Serum CXCR3 ligands and mycobacterial -specific 
Ab responses in IBD patients. Sera from 62 CD and 88 
UC female patients and 32 normal healthy female donors, 
not undergoing any treatment, were isolated and evaluated 
for the presence of CXCR3 ligands (i.e., CXCL9, CXCL10, 
and CXCL11) and mycobacterial-specific IgG1, IgG2, IgG3 
and IgG4 Abs. These levels were determined by ELISAs capa-
ble of detecting 10 > pg/ml of these ligands. The data pre-
sented are concentrations ± SEM. Asterisk(s) indicate 
statistically significant differences, i.e., p < 0.01, between 
healthy donors and IBD patients.BMC Immunology 2008, 9:25 http://www.biomedcentral.com/1471-2172/9/25
Page 5 of 13
(page number not for citation purposes)
expressed CXCR3, IFN-γ, and TNF-α from mice chal-
lenged with live bacilli were significantly higher than sim-
ilar mice challenged with heat-killed bacilli or the control
group. Dramatic increases in the number of PP CXCL11+
T cells, PP and LP CXCR3+ T cells and PP TNF-α+ T cells as
well as MLN TNF-α+ CD8+ T cell subsets were observed in
mice challenged with live bacilli than compared to other
groups (Figure 4). PP, MLN, and LP IFN-γ+ CD4+ T cells as
well as MLN and LP IFN-γ+ CD8+ T cells were significantly
elevated after livemycobacterial challenge. These results
imply that intestinal inflammation is driven in part by
effector site-derived (PP and LP) CXCR3+ TNF-α+ CD4+
and CD8+ T cells along with similar cells from PP that pro-
duce CXCR3 ligands as well as MLN (inductive site) IFN-
γ+ T cells to presumably support Th1-biased colitis.
Alteration of DC cytokine and CXCR3 ligands expression 
following Mycobacteria challenge
To further address the adaptive versus  innate leukocyte
subsets responsible for Mycobacteria-enhanced colitis in
IL-10-/- mice, we next assessed myeloid and plasmacytoid
DC phenotypes from MLN, PP, and LP after disease onset.
PP and MLN DCs expressed elevated levels of CXCL9 and
CXCL11, but not CXCL10, during Mycobacteria-enhanced
colitis as indicated by their relative mean fluorescent
intensities (Figure 5A). Interestingly, both DC subsets het-
erogeneously expressed CXCL9. The number of PP
Change in SAA levels in IBD patients and in IL-10-/- mice after  mycobacterial challenge Figure 2
Change in SAA levels in IBD patients and in IL-10-/- 
mice after mycobacterial challenge. Sera from 62 CD 
and 88 UC female patients and 32 normal healthy female 
donors, not undergoing any treatment, were isolated and 
evaluated for the presence of SAA. IL-10-/- mice on B6 back-
ground, received 200 μl of cream milk alone (m; control) or 
cream milk containing 104 CFU of live (l) or heat-killed (s) 
M. avium paratuberculosis. SAA levels during Mycobacteria-
enhanced colitis as well as IBD patients and healthy donors 
were measured by ELISA. Experimental groups consisted of 5 
mice, and experiments were repeated 3 times. The data pre-
sented are the mean ± SEM concentration of SAA. Asterisks 
indicate statistically significant differences, i.e., p < 0.01, 
between control and Mycobacteria-treated groups or healthy 
donors and IBD patients.
Intestinal histological characteristics of IL-10-/- mice chal- lenged with Mycobacteria Figure 3
Intestinal histological characteristics of IL-10-/- mice 
challenged with Mycobacteria. IL-10-/- mice on B6 back-
ground, received 200 μl of cream milk alone (m; control) or 
cream milk containing 104 CFU of live (l) or heat-killed (s) 
M. avium paratuberculosis. After sacrifice, intestines were 
fixed, sectioned at 6 μm, and stained with hematoxylin and 
eosin. Sections were examined by light microscopy. Experi-
mental groups consisted of 5 mice and experiments were 
repeated 3 times.BMC Immunology 2008, 9:25 http://www.biomedcentral.com/1471-2172/9/25
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CXCR3+ DCs was significantly higher in live Mycobacteria-
challenged mice than in other groups (Figure 5B). How-
ever, the number of MLN CXCR3+ plasmacytoid DCs was
significantly higher in mycobacterial-challenged mice
than in other groups of mice. The numbers of MLN and LP
DCs subsets expressing CXCL9 and CXCL11 after the
onset of colitis were significantly increased during live
Mycobacteria-enhanced colitis than in the other groups
Table 1: Histological evaluation of Mycobacteria-enhanced colitis in IL-10-/- mice
Treatment/Group Number of Mice Colitis Disease Score (0 – 12)
Live M. avium paratuberculosis 10 6.12 ± 2.01*
Pasteurized M. avium paratuberculosis 10 4.89 ± 1.41*
Control (vehicle only) 10 1.45 ± 0.79
Untreated wild-type B6 5 0
The severity of colitis was monitored by evaluating the histopathological changes in colons of IL-10-/- mice on B6 background that received 200 μl of 
cream milk or 104 CFU of live or heat-killed M. avium paratuberculosis in cream milk. Following the sacrifice of mice 14 weeks later, colons were 
fixed, sectioned at 6 μm and stained with hematoxylin and eosin. The sections were microscopically examined and scored for the severity of colitis. 
The data presented are the mean ± SEM colitis score. Asterisks indicate statistically significant differences, i.e., p < 0.01 between experimental and 
the control group.
Changes in the T cell populations expressing CXCR3, IFN-γ, TNF-α, and CXCR3 ligands in IL-10-/- mice after mycobacterial  challenge Figure 4
Changes in the T cell populations expressing CXCR3, IFN-γ, TNF-α, and CXCR3 ligands in IL-10-/- mice after 
mycobacterial challenge. MLN, PP, and LP lymphocytes were isolated from IL-10-/- mice challenged with cream milk alone 
(control) or 104 CFU of heat-killed or live M. avium paratuberculosis in cream milk. Changes in the frequency of LP CXCR3+ 
CD4+ T cells from heat-killed or live Mycobacteria-challenged and control mice (Panel A). Changes in the number (± SEM) of 
total IFN-γ-, TNF-α-, CXCR3-, CXCL9-, CXCL10- or CXCL11-expressing CD4+ and CD8+ T cell lymphocytes from control 
mice as well as heat-killed or live Mycobacteria-challenged IL-10-/- mice are shown in Panel B. Asterisks indicate statistically sig-
nificant differences, i.e., p < 0.01, between control and Mycobacteria-treated groups.BMC Immunology 2008, 9:25 http://www.biomedcentral.com/1471-2172/9/25
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with the exception of MLN CXCL10+ myeloid DCs that
were elevated following live bacterial challenge. While the
DCs subsets studied did not appear to significantly
express TNF-α, there were significantly more numbers of
MLN and PP CD8α+ DCs and only PP-derived CD8α- DCs
that expressed IFN-γ from mice with live Mycobacteria-
enhanced colitis, than compared to other groups. LP plas-
macytoid DCs from mice receiving live bacteria were also
increasingly IL-12p40+, than compared to other groups.
CXCR3, IFN-γ, TNF-α, IL-12, CXCL9, CXCL10 and 
CXCL11 expression by NK and NKT cells during 
Mycobacteria-enhanced colitis
NK cells act as regulators of CD4+ T cell-driven colitis [14].
While neither NK nor NKT cell subsets largely expressed
CXCR3, there were substantially more CXCL10+ NK cells
in the MLN, PP, and LP during Mycobacteria-enhanced col-
itis, than compared to other groups (Figure 6). IL-12p40
expression and the number of NK cell subsets were ele-
vated in mice challenged with live Mycobacteria than com-
pared to mice challenged with heat-killed Mycobacteria or
control mice. Whereas, greater numbers of IFN-γ+ NK and
NKT cells were confined to the MLN and LP in live Myco-
bacteria-challenged group than compared to other groups.
In contrast, we noticed a modest decrease in the number
of PP CXCR3+, IFN-γ+, CXCL9+ and CXCL11+ NK cells dur-
ing live Mycobacteria-enhanced colitis. These results sug-
gest that together NK and NKT cells express CXCL10, IL-
12p40, TNF-α and IFN-γ to recruit and activate CXCR3+
leukocytes to inductive and effector sites during Mycobac-
teria-enhanced colitis.
Th1-associated cytokines, CXCR3 and CXCR3 ligands 
expressed by neutrophils
Neutrophils are among the first cells to arrive at sites of
inflammation and infection. These cells also have the
capacity to release CXCL10 [15] and are present during
Mycobacteria-enhanced colitis. LP neutrophils signifi-
cantly expressed TNF-α, in a heterogenous fashion, fol-
lowing live mycobacterial challenge (Figure 7A). TNF-α+
neutrophils were largely retained in the LP during disease
when compared to other groups. MLN and LP, but not PP
or spleen, contained higher numbers of TNF-α+ and IFN-
γ+ neutrophils during Mycobacteria-enhanced colitis (Fig-
ure 7B). In contrast, higher numbers of IL-12p40+ and
CXCL10+ LY6G+ cells were found in PP and spleen, but
not in MLN of LP from live Mycobacteria-challenged mice
relative to control mice and heat-killed Mycobacteria-chal-
lenged mice. However, greater numbers of CXCL9+ and
CXCL11+ neutrophils were found in MLNs of live bacte-
ria-challenged mice, than compared to other groups.
These data suggest that neutrophils are compartmental-
ized and tightly regulated to differentially express CXCR3
ligands, CXCR3 and Th1-promoting cytokines during
Mycobacteria-driven colitis.
Discussion
Although there is no recognized or agreed on infectious
agent for IBD, interest in M. avium paratuberculosis as a
possible causative began due to similar signs and symp-
toms of JD and CD. For example, chronic granulomatous
and intramural inflammation is common in both CD and
JD; however, the precise pathophysiologic mechanisms
sustaining inflammation in these diseases are imprecisely
known. In confirmation with others [16,17], we show an
increase in Mycobacteria-specific IgG1 and IgG2 Abs in sera
from patients with active CD or UC. While the cellular
mechanism(s) and response(s) mediating Mycobacteria-
enhanced IBD have not been entirely demonstrated,
recently we showed that colitis in IL-10-/- mice was driven
in part by 85B Ag-specific CD4+ T cell responses [7]. As M.
avium paratuberculosis is a mycobactin auxotroph and is
not known to replicate outside a host, spontaneous colitis
of IL-10-/- mice upon transfer to conventional housing is
possibly the result of exposure to Mycobacterium species,
which are commonly found in soil and water. We illus-
trate several cellular mechanisms that may drive Mycobac-
teria-enhanced colitis in IL-10-/-  mice.  Mycobacteria-
challenged IL-10-/- mice housed under otherwise patho-
gen-free conditions develop colitis that is driven by
CXCR3- and corresponding ligand(s)-expressing leuko-
cytes, which underscores another important hallmark or
molecule mechanism of colitis.
The expression of CXCR3 and its ligands (CXCL10 >>
CXCL11 or CXCL9) by mucosal T cells significantly
increased in mice challenged with live Mycobacteria than
compared with similar mice challenged with heat-killed
Mycobacteria or controls. Our results also suggest plasma-
cytoid > > myeloid DCs express CXCL9 and CXCL11, but
less CXCL10 as well as IFN-γ to recruit, differentiate, and
expand Th1 cells to mediate colitis. NK cell and neu-
trophil subsets were compartmentalized in mucosal
inductive and/or effector site to further foster adaptive
Th1 responses through IFN-γ and IL-12p40 production as
well as TNF-α expression during colitis. Relatively high
levels of serum TNF-α and IFN-γ as well as Ag-specific Th1
responses were also noted in this model [7]. These find-
ings suggest an association between Mycobacteria and CD
patients as well as IL-10-/- murine colitis.
It is well established that IL-12 drives Th1 differentiation
and subsequent IFN-γ production [18]. We demonstrate
that local and/or systemic expression of the TNF-α, IFN-γ,
and CXCR3 ligands are increased during live Mycobacteria-
enhanced colitis. TNF-α is a proinflammatory cytokine
produced by leukocytes at local sites of inflammation
[19]. This cytokine is also important for the activation of
granulocytes and fibroblasts during CD [20]. LP lym-
phocytes produce significant amounts of TNF-α in IBD
tissues and secretary fluids [21-23]. Perhaps the produc-BMC Immunology 2008, 9:25 http://www.biomedcentral.com/1471-2172/9/25
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tion of CXCR3 ligands along with IFN-γ and TNF-α during
colitis progression creates a situation in which Th1 cells
are recruited, activated, further differentiated, and
expanded to initiate or maintain disease. While TNF-α
produced by CD4+ T cells is neither sufficient nor required
for the induction of murine colitis, its production by Ag-
presenting cells is essential for the histopathological and
clinical signs of colitis [24]. We show that NK cell subsets
and neutrophils, compared to T cells, expressed the great-
est levels of TNF-α during Mycobacteria-mediated colitis,
which is also a hallmark of spontaneous murine colitis.
The presence of CXCL10 is considered an important sig-
nal for selective homing and/or activation of effector cells,
which preferentially accumulate at inflammatory sites
[25]. Previously, we showed CXCL10 enhanced CD28 and
CD40 expression by Ag-activated CD4+ T cells [12] and
DC activation [26]. Plasmacytoid DCs have an inherent
capacity to produce large amounts of IFN-γ and DC acti-
vation is a critical step and is reported to be higher in CD
patients [27]. Intestinal LP DCs prime T cells and home to
MLN for further activation and clonal expansion of T cells
[28,29]. DCs can be found in the intestinal mucosal [30]
and have also been shown to produce and respond to
CXCR3 ligands [31]. In the present study, we show that
CXCL9 and CXCL11 are predominantly produced by DCs
in the MLN as well as in PP and to a lesser degree in the
intestinal LP. The selective expression of CXCL9 and
CXCL11 by plasmacytoid and myeloid DCs suggests a dif-
ferential role for these cells in the attraction of specific
lymphocyte subsets [10] as well as in the preferential
recruitment and activation of Th1 cells [11,32]. In a recent
study, mature DC-derived CXCR3 ligands were shown to
Changes in CD8α + and CD8α - CD11b+CD11c+ cells expressing CXCR3, IFN-γ, TNF-α, IL-12p40, and CXCR3 ligands in IL- 10-/- mice after mycobacterial challenge Figure 5
Changes in CD8α + and CD8α - CD11b+CD11c+ cells expressing CXCR3, IFN-γ, TNF-α, IL-12p40, and CXCR3 
ligands in IL-10-/- mice after mycobacterial challenge. MLN, PP, and LP lymphocytes were isolated from IL-10-/- mice 
challenged with cream milk alone (control) or cream milk containing 104 CFU of live or heat-killed M. avium paratuberculosis. 
Changes in the mean fluorescent intensities of CXCL9, CXCL10, and CXCL11 expressed by MLN CD8α+ and CD8α- 
CD11b+CD11c+ cells from control mice (shaded histogram) and heat-killed (dotted outlined histogram)- or live Mycobacteria 
(solid outlined histogram)-challenged mice are shown in Panel A. Changes in the number (± SEM) of CXCR3-, IFN-γ-, TNF-α-, 
IL-12p40-, CXCL9-, CXCL10- or CXCL11-expressing CD8α+ and CD8α- CD11b+CD11c+ cells from control mice as well as 
live or heat-killed Mycobacteria-challenged IL-10-/- mice are shown in Panel B. Asterisks indicate statistically significant differ-
ences, i.e., p < 0.01, between control and Mycobacteria-treated groups.BMC Immunology 2008, 9:25 http://www.biomedcentral.com/1471-2172/9/25
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be essential in Th1 cell retention in draining lymph nodes
and to optimize Th1-mediated immune responses [33].
NK cells have been shown to be involved in the differen-
tiation of naïve CD4+ T cells into Th1 cells [34]. The cur-
rent study suggests NK and NKT cells collaborate to
produce CXCL10, IL-12p40, TNF-α, and IFN-γ to recruit
and stimulate CXCR3+ leukocytes in either inductive or
effector sites during colitis. In IBD, neutrophil activation,
migration, and degranulation are important effector
mechanisms of intestinal damage [35]. It has been
reported that human neutrophils have the capacity to
release CXCL10 [15]. In the present study, changes in the
number of neutrophils that expressed CXCR3, IFN-γ,
CXCL9, and CXCL11 in the MLN, IL-12p40 and CXCL10
in PP as well as IFN-γ and TNF-α in LP of mice during
Mycobacteria-enhanced colitis suggest that neutrophil sub-
sets are differentially compartmentalized and regulated to
propagate colitis.
Activation of toll-like receptors (TLRs) leads to the induc-
tion of antimicrobial pathways central to innate defense
as well as upregulation of Ag presentation molecules and
secretion of cytokines that influence the nature of the sub-
sequent adaptive immune response. To this end, TLR sig-
nal transduction requires MyD88 [36,37]; MyD88-/- mice
are highly susceptible to infection by M. tuberculosis and
colitis [38]. TLR-activated DCs generally favor Th1
responses due in large part to the production of IL-12
[39,40]. Mycobacteria cell constituents have long been rec-
ognized as powerful immunologic adjuvants. It is plausi-
ble that Mycobacteria stimulate TLRs to promote colitis in
IL-10-/- mice, which presents a scenario where mycobacte-
Changes in NK and NKT cells of IL-10-/- mice challenged with Mycobacteria Figure 6
Changes in NK and NKT cells of IL-10-/- mice challenged with Mycobacteria. MLN, PP, and LP lymphocytes were iso-
lated from IL-10-/- mice challenged with cream milk alone (control) or cream milk containing 104 CFU of live or heat-killed M. 
avium paratuberculosis. Changes in the mean fluorescent intensities of IL-12p40, IFN-γ, and TNF-α expressed by LP CD3+ and 
CD3- NK1.1+ cells from control mice (shaded histogram) or heat-killed (dotted outlined histogram)- and live MAP (solid out-
lined histogram)-challenged mice are shown in Panel A. Changes in the number (± SEM) of CXCR3-, IFN-γ-, TNF-α-, IL-12p40-
, CXCL9-, CXCL10- or CXCL11-expressing by CD3+ and CD3- NK1.1+ cells from control mice and live or heat-killed Myco-
bacteria-challenged IL-10-/- mice are shown in Panel B. Asterisks indicate statistically significant differences, i.e., p < 0.01, 
between control and Mycobacteria-treated groups.BMC Immunology 2008, 9:25 http://www.biomedcentral.com/1471-2172/9/25
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rial recognition via TLR and MyD88 activate DCs to con-
trol Th1 polarization and expansion.
Live orally administered M. avium paratuberculosis do not
readily colonize or extensively replicate in the murine
host. The ability of this bacterial species to colonize and
replicate in man is also questionable. In fact, B6 mice are
only modestly susceptible to orally administered M.
avium paratuberculosis [41]. Granulomatous lesions con-
taining acid-fast bacteria develop in mesenteric lymph
nodes 11 months after oral challenge using 109 CFU. In
this study, 104 CFU of live M. avium paratuberculosis initi-
ated the development of colitis, but there was no evidence
of infection by histology (data not shown) or bacterial
culture [7]. Presumably, IL-10 deficiency or a host that
elicits Th1-biased immune responses to microbial chal-
lenge supports the development of colitis with either
undetectable or no growth of M. avium paratuberculosis.
Changes in cell populations of neutrophils during Mycobacteria-enhanced colitis Figure 7
Changes in cell populations of neutrophils during Mycobacteria-enhanced colitis. Spleen, MLN, PP, and LP lym-
phocytes were isolated from IL-10-/- mice challenged with cream milk alone (control) or cream milk containing 104 CFU of live 
or heat-killed M. avium paratuberculosis. Changes in the mean fluorescent intensities of IL-12p40, IFN-γ, and TNF-α expressed 
by LP CD3- LY6G+ cells from control mice (shaded histogram) or heat-killed (dotted outlined histogram)- and live Mycobacteria 
(solid outlined histogram)-challenged mice are shown in Panel A. Changes in the number (± SEM) of CXCR3-, IFN-γ-, TNF-α-, 
IL-12p40-, CXCL9-, CXCL10- or CXCL11-expressed by CD3- LY6G+ cells from control mice and live or heat-killed Mycobac-
teria-challenged IL-10-/- mice are shown in Panel B. Asterisks indicate statistically significant differences, i.e., p < 0.01, between 
control and Mycobacteria-treated groups.BMC Immunology 2008, 9:25 http://www.biomedcentral.com/1471-2172/9/25
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We speculate that innate (i.e., TLR agonists) and adaptive
(e.g., 85B protein) immunity antigens are better presented
by live M. avium paratuberculosis or recognized by the Th1-
biased host to modulate relevant cellular and molecular
mechanisms required by colitis development. Indeed,
persistent presentation of flora present in conventional
housing is required for colitis in IL-10-/- B6 mice. Hence,
heat-killed mycobacteria may not have allowed for this
sustained presentation and expression in the host. Addi-
tional studies using antibiotics along with or without live
or heat-killed bacteria (e.g., Citrobacter rodenticum, Myco-
bacterium avium hominissuis, etc.) will be necessary to
Possible cellular and molecular mechanisms of Mycobacteria-mediated colitis Figure 8
Possible cellular and molecular mechanisms of Mycobacteria-mediated colitis. The differential production of 
CXCR3 ligands and their recognition by CXCR3+ cells are involved in Mycobacteria-enhanced colitis. Regulatory T cells (Tr1) 
are critical to maintain tolerance or homeostasis in the presence of commensal flora. In a host (e.g., IL-10-/- or NOD2/CARD15 
or TLR polymorphisms) that is deficient in the regulation of tolerance, inactive dendritic cells (iDC) mature and aid in the dif-
ferentiation of precursor T helper cells (pT) to Th1 cells. These Th1 cells express CXCR3, TNF-α, and IFN-γ, while mature 
dendritic cells (mDC) and other activated antigen-presenting cells express CXCR3, CXCL9, CXCL11, and IL-12p40 to support 
Th1 development as well as the recruit of CXCR3- and CXCL10-expressing cells (e.g., CD8+ T cells, polymorphonuclear cells 
(PMN), natural killer (NK) and NK T cells (NKT)) for the propagation and recurrence of IBD, which correlates with increases 
in SAA, CXCR3 ligands, and anti-Mycobacteria IgG1 and IgG2 Abs.BMC Immunology 2008, 9:25 http://www.biomedcentral.com/1471-2172/9/25
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reveal the precise requirements for Mycobacteria-induced
colitis.
Conclusion
We can conclude that IBD patients have higher CXCL9,
CXCL10, and CXCL11 levels and Mycobacteria-specific
IgG1 and IgG2 Ab responses. These findings correlate with
our previous findings that show higher levels of Mycobac-
teria-specific IgG2a and CXCR3 ligands occur during
spontaneous colitis in IL-10-/- mice [7]. In short, colitis
was more aggressive in IL-10-/- mice that received live
Mycobacteria, than compared to similar mice that received
heat-killed bacilli or vehicle, housed under specific path-
ogen-free housing. It can be surmised that IL-12p40+ TNF-
α+ IFN-γ+ NK and NKT cells express CXCL10 to recruit and
activate CXCR3+ leukocytes to inductive and effector sites
during Mycobacteria-enhanced colitis (Figure 8). As with
these innate immunity cells, neutrophils are compart-
mentalized in the MLN and tightly regulated to differen-
tially express CXCL9 and CXCL11, CXCR3 and Th1-
associated cytokines during Mycobacteria-mediated colitis.
These results further show that murine colitis is driven in
part by effector site-derived CXCR3+ TNF-α+ CD4+ and
CD8+ T cells as well as inductive site IFN-γ+ T cells to sup-
port Th1-biased colitis. This response is enhanced or
maintained by high numbers of MLN and PP CD8α+ IFN-
γ+ DCs, PP-derived CD8α- IFN-γ+ DCs, and IL-12p40+ LP
plasmacytoid DCs. While additional studies will be
required to ascertain the precise role of Mycobacteria in the
induction and progression of colitis, we report that live
mycobacterial challenge accelerates chronic colitis in IL-
10-/- mice.
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